# Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy

> **NCT03471481** · — · TERMINATED · sponsor: **Drexel University** · enrollment: 7 (actual)

## Conditions studied

- Epilepsy
- Magnesium Deficiency
- Vitamin D Deficiency

## Interventions

- **OTHER:** No Intervention. Study is Cross Sectional in nature

## Key facts

- **NCT ID:** NCT03471481
- **Lead sponsor:** Drexel University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08-10
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Closure of Drexel University Hahnemann Hospital where Referring Physician Worked
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03471481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03471481, "Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03471481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*